tiprankstipranks
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market
TCRX
TScan Therapeutics
RESEARCH TOOLSreports
Want to see TCRX full AI Analyst Report?

TScan Therapeutics (TCRX) Revenue

376 Followers
StatisticsMarket CapRevenue

TScan Therapeutics Revenue

TScan Therapeutics had a revenue of 982.00K in the quarter ending Mar 31, 2026, with -61.75%. This bring the company's revenue in the last twelve months to 9.14M, Increased -11.52%. In the fiscal year ending Dec 31, 2025, TScan Therapeutics had annual revenue of 10.32M with 266.65% growth.
Revenue (ttm)
9.14M
Revenue Growth
106.65%
P/S Ratio
6.71
Revenue/Employee
$51,625
Employees
200
Market Cap
$69.27M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
10.32M7.51M+266.65%
Dec 31, 2024
2.82M-18.23M-86.62%
Dec 31, 2023
21.05M7.51M+55.52%
Dec 31, 2022
13.54M3.39M+33.47%
Dec 31, 2021
10.14M9.06M+834.65%
Dec 31, 2020
1.08M―+∞%
Dec 31, 2019
―――